PRDX1 Protein (Peroxiredoxin 1)

title: PRDX1 Protein (Peroxiredoxin 1)

PRDX1 (Peroxiredoxin 1) Protein

<div class="infobox infobox-protein">

| Property | Value |
|----------|-------|
| Protein Name | Peroxiredoxin 1 |
| Gene | PRDX1 |
| UniProt ID | Q06830 |
| PDB ID | 1XCC, 2Z9S, 5B6T, 4XWX |
| Molecular Weight | ~22 kDa |
| Subcellular Localization | Cytoplasm, nucleus, mitochondria |
| Protein Family | Peroxiredoxin family (2-Cys typical) |
| Expression | Ubiquitous, high in brain |

</div>

Overview

Peroxiredoxin 1 (PRDX1) is a 199-amino acid member of the typical 2-Cys peroxiredoxin family that serves as a central component of cellular antioxidant defense. Discovered as a ubiquitous antioxidant enzyme, PRDX1 has evolved from a simple H2O2-scavenging protein to a critical regulator of redox signaling, cellular stress responses, and neurodegenerative disease pathogenesis[@rhee2005].

PRDX1 possesses unique biochemical properties that distinguish it from other antioxidant enzymes. Its ability to undergo hyperoxidation (overoxidation of the catalytic cysteine to cysteine-sulfinic acid) and be regenerated by sulfiredoxin represents a sophisticated redox regulatory mechanism. This "peroxidase-thiolspecific peroxidase" function is essential for maintaining cellular [reactive oxygen species](/entities/reactive-oxygen-species) (ROS) homeostasis while permitting redox signaling.

title: PRDX1 Protein (Peroxiredoxin 1)

PRDX1 (Peroxiredoxin 1) Protein

<div class="infobox infobox-protein">

| Property | Value |
|----------|-------|
| Protein Name | Peroxiredoxin 1 |
| Gene | PRDX1 |
| UniProt ID | Q06830 |
| PDB ID | 1XCC, 2Z9S, 5B6T, 4XWX |
| Molecular Weight | ~22 kDa |
| Subcellular Localization | Cytoplasm, nucleus, mitochondria |
| Protein Family | Peroxiredoxin family (2-Cys typical) |
| Expression | Ubiquitous, high in brain |

</div>

Overview

Peroxiredoxin 1 (PRDX1) is a 199-amino acid member of the typical 2-Cys peroxiredoxin family that serves as a central component of cellular antioxidant defense. Discovered as a ubiquitous antioxidant enzyme, PRDX1 has evolved from a simple H2O2-scavenging protein to a critical regulator of redox signaling, cellular stress responses, and neurodegenerative disease pathogenesis[@rhee2005].

PRDX1 possesses unique biochemical properties that distinguish it from other antioxidant enzymes. Its ability to undergo hyperoxidation (overoxidation of the catalytic cysteine to cysteine-sulfinic acid) and be regenerated by sulfiredoxin represents a sophisticated redox regulatory mechanism. This "peroxidase-thiolspecific peroxidase" function is essential for maintaining cellular [reactive oxygen species](/entities/reactive-oxygen-species) (ROS) homeostasis while permitting redox signaling.

In the nervous system, PRDX1 plays indispensable roles in protecting neurons from oxidative damage, regulating inflammatory responses, and maintaining synaptic function. Its dysregulation has been strongly implicated in [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), [amyotrophic lateral sclerosis](/diseases/amyotrophic-lateral-sclerosis), and multiple sclerosis. This has made PRDX1 an attractive target for neuroprotective therapeutic strategies.

Structure

The PRDX1 protein exhibits sophisticated structural features that enable its diverse functions[@wood2003]:

Domain Architecture

• N-Terminal Resolving Cysteine (Cys52): The first conserved cysteine that forms a disulfide bond with the C-terminal cysteine during the catalytic cycle. This residue is essential for peroxidase activity.
• C-Terminal Resolving Cysteine (Cys173): The second critical cysteine that forms an intersubunit disulfide bond in the dimeric protein. This forms the characteristic 2-Cys peroxiredoxin disulfide.
• Active Site FVCP Motif (aa 49-52): The conserved motif containing the N-terminal resolving cysteine. This motif is critical for nucleophilic attack on peroxides.
• Thioredoxin Fold: The characteristic three-dimensional structure shared with thioredoxin and glutaredoxin families, providing the structural basis for redox activity.
• Decameric Oligomerization: PRDX1 forms toroidal decamers (doughnut-shaped 10-mers) composed of five dimers. This oligomerization modulates its chaperone function.
• Phosphorylation Sites: Multiple regulatory phosphorylation sites (Tyr194, Ser32) that modulate PRDX1 function in response to cellular signaling.

Catalytic Mechanism

The catalytic cycle involves:

Hyperoxidation and Regeneration

PRDX1 has a unique ability to become hyperoxidized (Cys-SO2/SO3) under high oxidative stress, which:

• Inactivates peroxidase activity
• Activates chaperone function
• Is regenerated by sulfiredoxin (Srx1)

Normal Function in the Nervous System

PRDX1 performs multiple essential functions in neurons and glia:

Antioxidant Defense

• Peroxide Reduction: PRDX1 efficiently detoxifies H2O2 and organic peroxides (t-butyl hydroperoxide, lipid peroxides). Its Km for H2O2 is in the micromolar range, making it a high-affinity peroxidase.
• Redox Signaling Modulation: Unlike simple scavengers, PRDX1 modulates cellular signaling by controlling H2O2 levels at the site of production, particularly near receptor tyrosine kinases and transcription factors.
• Protein Protection: PRDX1 prevents oxidative damage to proteins by reducing protein hydroperoxides before they cause irreversible oxidation of amino acid residues.
• DNA Protection: Guards against oxidative DNA damage by maintaining nuclear redox balance.

Chaperone Function

When hyperoxidized, PRDX1 transitions to a molecular chaperone:

• Aggregate Prevention: Hyperoxidized PRDX1 can prevent protein aggregation under stress
• Complex Formation: Forms large oligomeric complexes that sequester damaged proteins
• Refolding Assistance: Helps refold stress-denatured proteins

Cellular Signaling

PRDX1 regulates multiple signaling pathways:

• Nrf2-ARE Pathway: PRDX1 is both a target and regulator of Nrf2 transcriptional activity
• ASK1-JNK/p38: PRDX1 regulates stress-activated protein kinase pathways
• NF-κB Signaling: Modulates inflammatory signaling through redox regulation
• PI3K/AKT: Interactions with cell survival pathways

Inflammation Modulation

In glial cells (microglia, astrocytes):

• Regulates microglial activation and cytokine production
• Controls astrocyte inflammatory responses
• Modulates peripheral immune cell infiltration

Apoptosis Regulation

PRDX1 has complex, context-dependent effects on [apoptosis](/entities/apoptosis):

• Pro-survival: Under mild stress, PRDX1 protects against apoptosis
• Pro-apoptotic: Under extreme oxidative stress, hyperoxidized PRDX1 can promote cell death
• ASK1 Regulation: Binds and inhibits ASK1, preventing JNK-mediated apoptosis

Neuronal-Specific Functions

• Synaptic Protection: Preserves synaptic proteins from oxidative damage
• Myelin Maintenance: Protects oligodendrocytes from oxidative damage
• Neurogenesis: Supports neural stem cell function

Role in Disease

Alzheimer's Disease (AD)

PRDX1 dysfunction is strongly implicated in AD pathogenesis[@kang2018]:

Oxidative Stress

AD brain shows characteristic oxidative stress markers:

• PRDX1 is hyperoxidized (sulfinated) in AD brain, indicating overwhelming oxidative stress
• The hyperoxidized form cannot function as a peroxidase, creating a vicious cycle
• Levels of reduced PRDX1 are decreased, compromising antioxidant defense

[Amyloid-beta](/proteins/amyloid-beta) (Aβ) induces PRDX1 oxidation:

• Aβ exposure causes rapid PRDX1 oxidation and inactivation in neurons
• Loss of PRDX1 function amplifies Aβ-induced oxidative damage
• PRDX1 overexpression protects against Aβ toxicity in model systems

PRDX1 affects [tau](/proteins/tau) phosphorylation and aggregation:

• Oxidative stress promotes tau hyperphosphorylation
• PRDX1 deficiency accelerates tau pathology in models
• Hyperoxidized PRDX1 may directly interact with tau aggregates

PRDX1 loss affects synaptic compartments:

• Synaptic PRDX1 is specifically reduced in AD
• Loss correlates with cognitive decline
• Synaptic proteins are particularly vulnerable to PRDX1 deficiency

• Nrf2 activators: Increase PRDX1 expression (sulforaphane, bardoxolone methyl)
• Protein therapy: Recombinant PRDX1 (limited by BBB)
• Gene therapy: AAV-PRDX1 in development

Parkinson's Disease (PD)

PRDX1 is implicated in multiple aspects of PD pathogenesis[@liu2020]:

Dopaminergic Neuron Protection

PRDX1 protects SNc neurons:

• PRDX1 expression is high in dopaminergic neurons under normal conditions
• PD-linked toxins (MPTP, 6-OHDA) cause PRDX1 oxidation and loss
• PRDX1 knockout mice are more susceptible to parkinsonian toxins

PRDX1 modulates [alpha-synuclein](/proteins/alpha-synuclein) (α-syn) aggregation:

• Oxidative stress promotes α-syn aggregation
• PRDX1 can reduce α-syn oxidation and oligomerization
• PRDX1 deficiency accelerates α-syn pathology

PRDX1 variants may modify PD risk:

• Certain PRDX1 polymorphisms associated with altered PD risk
• Gene-environment interactions (e.g., pesticide exposure + variant)

PRDX1 modulates microglial responses:

• Controls excessive microglial activation
• Regulates cytokine production in the substantia nigra
• Affects peripheral immune cell infiltration

Amyotrophic Lateral S sclerosis (ALS)

PRDX1 alterations in ALS:

Motor Neuron Vulnerability

• PRDX1 is reduced in ALS motor neurons
• Mutant SOD1 causes PRDX1 oxidation and dysfunction
• PRDX1 overexpression partially rescues mutant SOD1 toxicity

• Motor neurons have high baseline oxidative stress
• PRDX1 deficiency cannot compensate in ALS
• Peroxynitrite (ONOO-) particularly damaging

• PRDX1 interacts with mutant SOD1 aggregates
• May be sequestered into inclusions
• Loss of function compounds proteostasis failure

Multiple Sclerosis (MS)

PRDX1 in demyelinating disease:

• Reduced in active demyelinating lesions
• Contributes to oligodendrocyte vulnerability
• Potential therapeutic target

Therapeutic Targeting

Clinical Status

| Approach | Status | Notes |
|----------|--------|-------|
| Nrf2 activators | Phase 2 | Increase PRDX1 expression |
| Sulforaphane | Phase 1-2 | Dietary Nrf2 activator |
| Bardoxolone methyl | Phase 2 | Nrf2 activator in MS |
| Gene therapy | Preclinical | AAV-PRDX1 |

Experimental Strategies

Small Molecules

• Nrf2 activators: Sulforaphane, oltipraz, bardoxolone methyl
• Direct PRDX1 stabilizers: Prevent hyperoxidation
• Sulfiredoxin activators: Enhance PRDX1 regeneration

• Recombinant PRDX1: Limited by BBB penetration
• Cell-penetrating peptides: PRDX1-derived peptides
• PRDX1 mimetics: Designed antioxidant peptides

• AAV-PRDX1: CNS-targeted delivery
• CRISPR activation: Increase endogenous expression

• Nrf2 activators + antioxidants: Synergistic effects
• PRDX1 + other peroxiredoxins: Broader redox protection
• Redox modulation + anti-inflammatory: Multi-target strategies

Mechanism of Action

Redox Regulation Network

Signaling Pathway Interactions

Nrf2-ARE Pathway

PRDX1 is both upstream and downstream of Nrf2:

• Nrf2 transcriptionally activates PRDX1
• PRDX1 helps maintain Nrf2 activity by reducing Keap1
• This creates a positive feedback loop

• PRDX1 binds and inhibits ASK1
• Oxidative stress disrupts this interaction
• Releases ASK1 to activate JNK/p38 apoptosis pathways

• PRDX1 regulates NF-κB activation via IKK redox status
• Controls inflammatory gene expression
• Modulates microglial activation

Key Publications

Cross-links

• [PRDX1 Gene](/genes/prdx1) — Gene page for PRDX1
• [Alzheimer's Disease](/diseases/alzheimers-disease) — Disease page with PRDX1 involvement
• [Parkinson's Disease](/diseases/parkinsons-disease) — Disease page with PRDX1 involvement
• [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis) — Disease page with PRDX1 involvement
• [Oxidative Stress Pathway](/mechanisms/oxidative-stress) — Core mechanism
• [Nrf2 Signaling Pathway](/mechanisms/nrf2-signaling) — Related pathway

External Links

• [Human Protein Atlas: PRDX1](https://www.proteinatlas.org/ENSG00000117450-PRDX1)
• [UniProt: PRDX1](https://www.uniprot.org/uniprotkb/Q06830)
• [RedoxDB: PRDX1](https://www.freeadd.com/redoxdb/PRDX1)

See Also

• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
• [Oxidative Stress Pathway](/mechanisms/oxidative-stress)
• [Nrf2 Signaling Pathway](/mechanisms/nrf2-signaling)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving PRDX1 Protein (Peroxiredoxin 1) discovered through SciDEX knowledge graph analysis: